AiXin Life International, Inc. reported a significant decline in financial performance for the fiscal year ending December 31, 2025, with total revenue of $1.49 million, a decrease of 61% from $3.82 million in 2024. The company experienced losses across its various segments, including direct sales, pharmacy operations, and manufacturing. The net loss for 2025 was $2.04 million, down from a loss of $2.77 million in the previous year, indicating a slight improvement in operational efficiency despite the overall revenue drop. The company attributed the revenue decline to an economic downturn that affected marketing and promotional activities, leading to reduced sales across its channels.
In terms of operational changes, AiXin Life International completed the acquisition of Yunnan Runcangsheng Technology Co., Ltd. in September 2022, which has allowed the company to enhance its product offerings and vertical integration capabilities. The company also operates eight pharmacies in Chengdu, which serve as distribution points for its health and wellness products. However, pharmacy revenue plummeted by 87% to $107,198 in 2025, reflecting the challenges faced in physical retail due to the growing preference for online shopping. The hotel segment also saw a revenue decrease of 30%, contributing to the overall decline in income.
The company has been proactive in addressing its operational challenges by implementing a liquidity plan aimed at improving cash flow and reducing costs. As of December 31, 2025, AiXin Life reported a working capital deficit of $7.48 million and cash reserves of $20,751, raising concerns about its ability to continue as a going concern. The management plans to raise additional funds through loans and potential equity offerings to support ongoing operations and future growth initiatives.
AiXin Life's employee count stood at approximately 116 as of May 2026, with a focus on enhancing customer engagement through well-trained staff. The company emphasizes a personalized marketing approach, which it believes is essential for promoting health and wellness products effectively. Despite the challenges, AiXin Life remains committed to expanding its market presence in China, particularly among the growing middle class, and is exploring opportunities for further acquisitions and product line expansions.
Looking ahead, AiXin Life International acknowledges the uncertainties in the market and the competitive landscape, particularly in the health and wellness sector. The company is focused on improving its operational efficiency and product offerings while navigating the complexities of the regulatory environment in China. The management's outlook remains cautious, with an emphasis on executing its liquidity plan and adapting to changing consumer preferences to achieve sustainable growth.
About AiXin Life International, Inc.
AiXin Life International, Inc. is a Colorado holding company operating primarily in China through subsidiaries. It develops, manufactures, markets, and sells premium health and wellness products, including traditional Chinese remedies, nutritional supplements, and functional foods. Serving China’s growing middle class, AiXin employs an omni-channel model combining pharmacies, direct marketing, online sales, and wholesale distribution. Its vertically integrated approach includes in-house R&D, manufacturing, and personalized customer support to differentiate in a competitive market.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.